Increased RAMP1 expression was strongly associated with the upregulation of lymphocyte activation gene 3 (LAG3), vascular endothelial growth factor B (VEGFB), and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) across multiple cancer types (Fig 2A). The gene discussed is CTLA4; the disease is cancer.